NeuroPrex Competitive Advantage

Better therapeutic outcomes for doctors and patients alike, with Neuroprex state of the art depression treatment.

Neuroprex state of the art depression treatment

Existing TMS treatments takes 20-30 continuous sessions, 30-40 min per session to complete a therapeutic course. the best therapeutic outcome over this long and dedicated process requires diligent cooperation between patient and doctor.

Instead, NPX provides an easy to use and simple procedure.
NPX's precisely positioned coils improve effectiveness and efficacy.  This better therapeutic outcome will be welcomed by doctors and patients for the immediate and lasting results, reaching the goal of a fast healing period without adverse side effects.
NeuroPrex surface pain reduction™ technology makes TMS therapy comfortable, free of scalp pain and headaches which other TMS systems can cause.

Doctors' costs to sustain a profitable TMS Therapy business are significantly reduced, through a flexible, unlimited use, monthly NPX subscription fee.
No dedicated office or treatment space is needed, reducing indirect business overhead expenses.
Home-treatment to relieve acute symptom is also possible.

Reimbursement codes are available for claiming coverage from most insurance companies, given the potential to remove reliance on drugs. Neuroprex NPX can also treat related syndromes, such as PTSD, Alzheimer's, Parkinson's, stroke rehab and pain mitigation.

 

NSF Award and EC's Seal of Excellence

NeuroPrex received National Science Foundation (NSF) SBIR award in 2018 and Seal of Excellence in 2017-2018 from the European Commission (EC) Horizons 2020 SME Instrument: "The NPX is a ground breaking repetitive TMS device treating depression.” This award recognizes the exceptional quality of NPX innovation, business planning and team work. NPX device has unique design features, producing magnetic pulses with doubled strength and precision to reach deeper lesion areas, is designed to comply with FDA safety requirements. Under the protection of NPX device, 32% of surface unwanted energy is eliminated without affecting the healing energy at the deeper target regions of the brain and the overheated spot disappears on the top of the patient’s head in the simulation diagram. The data supporting these findings was presented in the annual meetings of National Academy of Neuropsychology (NAN) 2016 and Society for Brain Mapping and Therapeutics (SBMT) 2017.